Clinical trial NCT01275534: Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation
Official title: Patient Reported Outcomes in View of Symptom Experience of Late Effects and Self-management After Haematopoietic Stem Cell Transplantation - A Mixed Methods Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hematologic Neoplasms
Keywords: Stem cell transplantation
Symptom experience
Late effects
Self-management
Lead sponsor: University Hospital, Basel, Switzerland
Sponsor class: OTHER
Collaborators: name: University of Basel
name: University Hospital, Zürich
First posted: 2011-01-12
Enrollment: 375
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Long-term survivors after allogeneic stem cell transplantation

Brief summary: In the study PROVIVO, a patient reported outcome instrument consisting of items from the PRO-CTCAE item bank measuring symptom experience of long-term survivors after allogeneic hematopoietic stem cell transplantation (SCT) will be developed. The instrument development is based on cognitive patient interviews, a survey of hematology experts and a literature review. In a subsequent cross-sectional study phase, the instrument will be validated in a sample of 300 allogeneic stem cell recipients and by the use of additional self report instruments it will be possible to explore how subjective symptom experience, problems in self-management and presence of late effects are connected.

Detailed description: Long-term survivors after allogeneic SCT are presumably at a life-long increased risk for developing various adverse side effects; also termed 'late effects'. Late effects may appear months or years after treatment has ended, can persist chronically and may be experienced as rather distressing and burdensome. Since most late effects are only experienced subjectively in the form of physical and mental symptoms and are seldom captured during objective clinician-based evaluations, using self-report instruments is important for the early detection, management and alleviation of these symptoms. The collection of self-report data in studies and clinical practice is strongly recommended by the National Cancer Institute (NCI): they developed a Patient-Reported Outcomes bank based on the well established Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Besides managing symptoms associated with late-effects, patients with SCT are also requested to manage their emotions associated with having a chronic illness, their new life roles in order to have a meaningful, fulfilling life, and their medical regimen, in view of taking medications, smoking cessation, regularly exercising and monitoring for signs of infection. However, evidence investigating the prevalence of problems related to these complex set of self-management tasks is scarce.

Aims:

* To translate the PRO-CTCAE items into German in a culturally-sensitive way and to develop the content of a self-report instrument measuring symptom experience after allogeneic SCT
* To validate the newly developed scale and assess its psychometric properties
* To examine self reported symptom experience and objective measured late effects in 300 adult survivors ≥ 1 year after SCT
* To describe self-management behaviours in 300 adult survivors ≥ 1 year after SCT
* To assess the relationship between symptom experience and objective burden of late effects, survivors' perception of late effects and self-management in view of managing emotions, managing new life roles and managing medical and health tasks in 300 adult survivors ≥ 1 year after allogeneic SCT

Eligibility criteria: Inclusion Criteria:

* Having received allogeneic SCT for haematological disease
* ≥ 1 year of follow-up experience after treatment
* Ability to understand and read German and having signed the written informed consent

Exclusion Criteria:

* Patients with psychiatric illness that in the opinion of physicians prevent them from participating
* Visual and/or hearing impairment which hinders participation in an interview/fill-out a questionnaire
* Being illiterate
* Actual acute care hospitalization stay at interview date
* Terminal illness

Primary outcomes:
measure: Symptom experience
timeFrame: single measuring point at ≥ 1 year after HSCT
Secondary outcomes:
measure: Perception of late effects
timeFrame: single measuring point at ≥ 1 year after HSCT
measure: Self-management behaviors
timeFrame: single measuring point at ≥ 1 year after HSCT
measure: Self-management in view of medical and health tasks, emotional and role tasks
timeFrame: single measuring point at ≥ 1 year after HSCT
measure: Objective late effects
timeFrame: single measuring point at ≥ 1 year after HSCT
Other outcomes:
Locations:
city: Basel
country: Switzerland
facility: University Hospital Basel
city: Zürich
country: Switzerland
facility: University Hospital Zürich
Study officials:
affiliation: University of Basel
name: Sabina De Geest, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2015 Feb;19(1):66-74. doi: 10.1016/j.ejon.2014.07.007. Epub 2014 Sep 1.